Jeffrey D. Klenc, Ph.D.

191 Peachtree Street NE, Suite 3800
Atlanta, GA 30303
D: 404.954.5062
Contact My Assistant
Kathrine B. Dean
D: 404.954.5076

Jeff is a member of Merchant & Gould's chemical and life sciences law practice group in Atlanta. Jeff’s technical background is developed from nearly a decade in academic research which spanned medicinal chemistry and pharmaceutical development projects between his Ph.D. work at Georgia State University, and post-doctoral research at Emory University. At Emory, Jeff worked to develop more efficient renal radiotracers to assess kidney function, and his efforts contributed to identification of several promising new renal agents which are currently awaiting clinical evaluation. These successes in the lab led to interactions with the Emory University Office of Technology Transfer, sparking Jeff's interest in the protection of research efforts through patent law.

Jeff developed his interest in patent law by completing an internship with the Emory University Office of Technology Transfer, where he participated in patent prosecution and invention disclosures with university inventors. Jeff also worked with Cardinal IP, where he conducted preliminary searches and examinations of PCT applications received at the USPTO. With this experience, Jeff joined Merchant & Gould as a Patent Agent, and has since completed law school. Jeff’s practice now focuses on patent prosecution, with specialization in chemical, pharmaceutical, and polymer technologies. Jeff’s search experience also allows him to contribute to freedom-to-operate, patentability, and due diligence analyses across a broad set of life sciences technologies, as well as technologies in other fields.


Georgia State University
J.D. In Progress

Georgia State University
Ph.D. Organic Chemistry, 2010

Georgia Southern University
B.S. Chemistry, 2006


U.S. Patent and Trademark Office, 2015

Professional Affiliations

American Chemical Society
Society of Nuclear Medicine and Molecular Imaging

Awards & Recognition

2012 Mitzi & William Blahd, MD Pilot Research Grant

Publications & Speaking

Big Changes in International IP Laws: Business Methods and Computer Programs in China and Copyright Protection for Digital Technologies in Europe, Author, Amercian Bar Association, June 2018.

Klenc, J; Lipowska, M; Abhayawardhana, P; Taylor, AT; Marzilli LG. Structure and Properties of fac-ReI(CO)3(NTA)2- (NTA3- = Tri-anion of Nitrilotriacetic Acid) and  fac-ReI(CO)3(L)n- Analogs Useful for Assessing the Excellent Renal Clearance of the fac- 99mTcI(CO)3(NTA)2- Diagnostic Renal Agent. Inorg. Chem. In revision.

Klenc, J; Lipowska, M; Taylor AT. Identification of lead compounds for 99mTc and 18F GPR91 radiotracers. Bioorg. Med. Chem. Lett. In press.

Lipowska M, Klenc J, Folks R, Taylor AT. Initial evaluation of 99mTc(CO)3(ASMA) as a renal tracer in healthy human volunteers. Nucl. Med. Mol. Imaging. 2014, 48(3): 216-224.

Lipowska M, Klenc J, Shetty D, Nye JA, Shim H, Taylor AT. Al18F-NODA-butyric acid: biological evaluation of a new PET renal tracer. Nucl. Med. Biol. 2014, 41(3): 248-253.

Klenc J, Lipowska M, Marzilli LG, Taylor AT.  Synthesis and characterization of fac-Re(CO)3-aspartic-N-monoacetic Acid: Structural Analogue of a Potential Renal tracer, fac-99mTc(CO)3(ASMA).  Eur. J. Inorg. Chem. 2012, 27: 4334-4341.

Klenc J, Strekowski L.  Synthesis of piperzino-substituted benzo[b]furans as potential CNS agents. Het. Comm. 2010, 16(4-6): 249-252.